학술논문

Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial
Document Type
Article
Source
In The American Journal of Clinical Nutrition July 2024 120(1):66-79
Subject
Language
ISSN
0002-9165
Abstract
Conclusions Improvements in gut microbiota-dependent BA metabolism and TGR5 activation after 24-wk curcumin intervention were associated with a reduction in hepatic fat content in patients with NASFL, providing evidence that curcumin is a potential nutritional therapy for NASFL.The trial was registered at www.chictr.org.cn as ChiCTR2200058052.